Latest News and Press Releases

Two independent campaigns in NYC spotlight healthcare and legal reform amid public outcry over Luigi Mangione’s case.

“Longtime advocate for religious minorities lauds Trump family's leadership during private meeting at Mar-a-Lago, citing urgent need for global action in Bangladesh.” Photo: Bangladeshi activist...

Judge rules against MFIN/Murstein. Murstein now looking to settle. Board structure does not protect stockholders. Murstein must be held accountable

CARACAS, Venezuela, Jan. 03, 2025 (GLOBE NEWSWIRE) -- The "FreeJesusArmas.com" campaign brings attention to the arbitrary detention of Jesús Armas, a respected Venezuelan activist, human rights...

2Q24 results show worrying trends that must be addressed immediately.Core charge-offs (YoY), ROAA, ROAE and holding company cash-burn trended poorly.Quarterly earnings, ROAA and core ROAA (Ex. Taxi...

Believes Socially Responsible Investment Principles Support FCM’s Plan to Bring MM-120 To the Market in 2026 to Benefit Millions with Mental Health Disorders FCM Directors Will Put in Place Strict...

ISS Dismissed 47% Stock Price Drop Following September 2022 Financing as In Line with “Sectoral Trends”, in a Baffling Lack of Critical Analysis and Seemingly in Opposition to the Factual...

FCM Predicts That the Psychedelic Revolution Will Begin with the FDA’s Likely Groundbreaking Approval of the Drug MDMA, Which is Expected to Occur in the Second Half of 2024 Reiterates that MindMed...

FCM Director Candidates, including Dr. Freeman, and Mr. Jake Freeman, Commit to Not Selling Any of Their MindMed Shares Until June 15, 2025 FCM and its Nominees Stand Behind Their Plan to Drive Value...

MindMed has Slashed Allocation of Spending on Core Drugs While Executive Compensation has Soared to $51M MindMed Phase IIb Clinical Trial Delayed Greenleaf Health Study, Quoting FDA, Supports FCM’s...